CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 10 of the 19 sources its claims cite were checked for support.

Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial

Open access

Abstract

Dietary fibers/probiotics may relieve constipation via optimizing gut microbiome, yet with limited trial-based evidences. We aimed to evaluate the effects of formulas with dietary fibers or probiotics on functional constipation symptoms, and to identify modulations of gut microbiota of relevance. We conducted a 4-week double-blinded randomized placebo-controlled trial in 250 adults with functional constipation. Intervention: A: polydextrose; B: psyllium husk; C: wheat bran + psyllium husk; D: Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001; Placebo: maltodextrin. Oligosaccharides were also included in group A to D. 16S rRNA sequencing was used to assess the gut microbiota at weeks 0, 2, and 4. A total of 242 participants completed the study. No time-by-group effect was observed for bowel movement frequency (BMF), Bristol stool scale score (BSS), and degree of defecation straining (DDS), while BSS showed mean increases of 0.95–1.05 in group A to D (all P < 0.05), but not significantly changed in placebo (P = 0.170), and 4-week change of BSS showed similarly superior effects of the interventions as compared placebo. Group D showed a marginal reduction in plasma 5-hydroxytryptamine. Group A resulted in a higher Bifidobacterium abundance than placebo at week 2 and 4. Fourteen genera showed intervention-specific increasing or decreasing trends continuously, among which Anaerostipes showed increasing trends in groups B and C, associated with BMF increase. Random forest models identified specific baseline microbial genera panels predicting intervention responders. In conclusion, we found that the dietary fibers or probiotics may relieve hard stool, with intervention-specific changes in gut microbiota relevant to constipation relief. Baseline gut microbiota may predispose the intervention responsiveness. ClincialTrials.gov number, NCT04667884.

Overview

CoChat Summary

TL;DR

In a 4-week double-blinded randomized placebo-controlled trial among 250 Chinese adults with functional constipation, dietary fiber or probiotic formulas improved hard stool (BSS) but did not show time-by-group effects for bowel movement frequency or straining. Intervention-specific gut microbiota changes and baseline microbial panels were associated with constipation relief and predicted intervention responsiveness.

Key findings

  • No time-by-group effect was observed for BMF, BSS, or DDS (all interaction P > 0.05); all groups, including placebo, had within-group increases in BMF and decreases in DDS (all P < 0.05).
  • BSS increased significantly in all four intervention groups (all P < 0.001) but not in placebo (P = 0.170); 4-week BSS change versus placebo had P values of 0.056, 0.037, 0.058, and 0.042 for groups A–D, with mean BSS increases of 0.95–1.05.
  • Group A had higher Bifidobacterium abundance than placebo at week 2 (difference 1.780%, FDR P = 0.027) and week 4 (2.930%, FDR P = 0.049); group B had lower Alistipes at week 2 (1.967%, FDR P = 0.020).
  • Fourteen genera showed continuous intervention-specific trends; Anaerostipes increased in groups B and C and was positively correlated with BMF change. Random forest models using baseline genera predicted responders with mean AUC > 0.8, including AUC 0.975 for ≥1-unit BMF increase in group B and 0.976 for ≥1-unit BSS increase in group C.

Methods

  • Double-blind, randomized, placebo-controlled trial in 250 adults with Rome IV functional constipation; 242 completed. Five groups (n = 50 each): A polydextrose + oligosaccharides + resistant dextrin; B psyllium husk + oligosaccharides + D-mannitol; C wheat bran + psyllium husk + oligosaccharides + resistant dextrin; D Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001 + oligosaccharides; placebo maltodextrin.
  • Primary outcome was BMF; secondary outcomes included BSS, DDS, fasting glucose, lipids, plasma 5-HT, and gut microbiome profiles. 16S rRNA sequencing assessed microbiota at weeks 0, 2, and 4.
  • Analyses used GEE adjusted for age and sex, Wilcoxon rank-sum tests, partial Spearman correlations, soft clustering with Mfuzz, PICRUSt2 for KEGG inference, and random forest models for predicting responders.

Limitations

  • Stated by the authors: no constipation sub-categorization, so effects by constipation type (e.g., dyssynergic defecation) could not be detected; no microbial metabolite data; wide age range may increase gut microbiota variability; KEGG annotations from 16S rRNA have limited resolution.
  • Evident from the text: the primary symptom BMF and DDS showed no significant time-by-group effects, and placebo also improved BMF and DDS, limiting attribution of those improvements to the interventions.
  • Evident from the text: several microbiota–symptom and 5-HT correlations did not sustain FDR adjustment, and BSS comparisons with placebo were marginal for some groups.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/19490976.2023.2197837

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1. The changes of constipation symptoms from baseline to week 2 and week 4 by group.
Figure 1. The changes of constipation symptoms from baseline to week 2 and week 4 by group.CC BY-NC · PubMed Central
Figure 2. Changes in 5-HT and correlations with gut microbiota.
Figure 2. Changes in 5-HT and correlations with gut microbiota.CC BY-NC · PubMed Central
Figure 3. The baseline correlations between gut microbial abundance and constipation symptoms, and the difference in relative abundance of the top 10 genera between intervention groups and placebo group at different stages.
Figure 3. The baseline correlations between gut microbial abundance and constipation symptoms, and the difference in relative abundance of the top 10 genera between intervention groups and placebo group at different stages.CC BY-NC · PubMed Central
Figure 4. Constant genera abundance changes over the intervention and selected relevance with constipation.
Figure 4. Constant genera abundance changes over the intervention and selected relevance with constipation.CC BY-NC · PubMed Central
Figure 5. Baseline gut microbiota predicting the improvement of constipation symptoms upon interventions.
Figure 5. Baseline gut microbiota predicting the improvement of constipation symptoms upon interventions.CC BY-NC · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 5 Not checked · 66 Own results and interpretations

32 more claims

Create a free account to see all 78 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 25

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 35 references

Research works printed but not linked: 3

  1. Chinese Nutrition Society. Dietary guidelines for Chinese residents. Beijing: Renmin Wei Sheng Chu Ban She; 2016.
  2. Gastrointestinal Dynamics Group of Gastroenterology Branch of Chinese Medical Association, Collaborative Group of Functional Gastrointestinal Diseases. Expert consensus on chronic constipation in China (2019, Guangzhou). Zhong Hua Xiao Hua Bing Za Zhi. 2019;39:577–598.
  3. Zhang B, Baibing M, Wentao W, Guoshuai S, Suhang S, Yezhou L, Xiangyu GA, Shaonong DA, Xiangyu GA, Hong YA, et al. Application of research electronic data capture in an interactive online survey system for monitoring hypertension risk factors during pregnancy. Xi’an Jiao Tong da Xue Xue Bao Yi Xue Ban. 2020;41(4):612-616.

Cited by

See all 208

Metadata

Authors
Lai, H., Li, Y., He, Y., Chen, F., Mi, B., Li, J., Xie, J., Ma, G., Yang, J., Xu, K., Liao, X., Yin, Y., Liang, J., Kong, L., Wang, X., Li, Z., Shen, Y., Dang, S., Zhang, L., Wu, Q., Zeng, L., Shi, L., Zhang, X., Tian, T., & Liu, X.
Affiliations
  • Xi'an Jiaotong University (CN)
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Tang Du Hospital (CN)
  • BYHEALTH Institute of Nutrition &amp; Health, Guangzhou, China
  • Shaanxi Normal University (CN)
  • Department of Nutrition, Xi’an Daxing Hospital, Xi’an, China
Corresponding author
  • Zhang, Xuguang
  • Tian, Tian
  • Liu, Xin
Venue
Gut Microbes
Published
2023-04-20
Volume
15
Issue
1
Pages
2197837-2197837
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4366486302
Cited by
208
References
35
Citations by year
2026: 60 · 2025: 88 · 2024: 48 · 2023: 12
FWCI
59.00
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Xi’an Jiaotong University (xjj2018146)
  • BYHEALTH Nutrition and Health Research Foundation (TY0191118)
  • National Natural Science Foundation of China (82173504)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
functional constipation, dietary fiber, probiotics, gut microbiota, polydextrose, psyllium husk, wheat bran, oligosaccharides, serotonin, Bifidobacterium, Anaerostipes, Bristol stool scale, stool frequency, defecation straining
MeSH terms
Gastrointestinal Microbiome, Bifidobacterium animalis, Adult, Constipation, Dietary Fiber, Double-Blind Method, Gastrointestinal Diseases, Humans, Psyllium, RNA, Ribosomal, 16S, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. https://app.cochat.ai/papers/10.1080/19490976.2023.2197837
The paper
Lai, H., Li, Y., He, Y., Chen, F., Mi, B., Li, J., Xie, J., Ma, G., Yang, J., Xu, K., Liao, X., Yin, Y., Liang, J., Kong, L., Wang, X., Li, Z., Shen, Y., Dang, S., Zhang, L., . . . Liu, X. (2023). Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes. https://doi.org/10.1080/19490976.2023.2197837

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.